|
|
Line 3: |
Line 3: |
| <StructureSection load='5fpd' size='340' side='right'caption='[[5fpd]], [[Resolution|resolution]] 1.97Å' scene=''> | | <StructureSection load='5fpd' size='340' side='right'caption='[[5fpd]], [[Resolution|resolution]] 1.97Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[5fpd]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FPD OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5FPD FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5fpd]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FPD OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5FPD FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=PZA:PYRAZINE-2-CARBOXAMIDE'>PZA</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.97Å</td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5fp5|5fp5]], [[5fp6|5fp6]], [[5fpe|5fpe]], [[5fpm|5fpm]], [[5fpn|5fpn]], [[5fpo|5fpo]], [[5fpr|5fpr]], [[5fps|5fps]], [[5fpt|5fpt]], [[5fpy|5fpy]]</td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=PZA:PYRAZINE-2-CARBOXAMIDE'>PZA</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5fpd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fpd OCA], [http://pdbe.org/5fpd PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fpd RCSB], [http://www.ebi.ac.uk/pdbsum/5fpd PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5fpd ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5fpd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fpd OCA], [https://pdbe.org/5fpd PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5fpd RCSB], [https://www.ebi.ac.uk/pdbsum/5fpd PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5fpd ProSAT]</span></td></tr> |
| </table> | | </table> |
| == Function == | | == Function == |
- | [[http://www.uniprot.org/uniprot/HSP72_HUMAN HSP72_HUMAN]] In cooperation with other chaperones, Hsp70s stabilize preexistent proteins against aggregation and mediate the folding of newly translated polypeptides in the cytosol as well as within organelles. These chaperones participate in all these processes through their ability to recognize nonnative conformations of other proteins. They bind extended peptide segments with a net hydrophobic character exposed by polypeptides during translation and membrane translocation, or following stress-induced damage. | + | [https://www.uniprot.org/uniprot/HSP72_HUMAN HSP72_HUMAN] In cooperation with other chaperones, Hsp70s stabilize preexistent proteins against aggregation and mediate the folding of newly translated polypeptides in the cytosol as well as within organelles. These chaperones participate in all these processes through their ability to recognize nonnative conformations of other proteins. They bind extended peptide segments with a net hydrophobic character exposed by polypeptides during translation and membrane translocation, or following stress-induced damage. |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 23: |
Line 23: |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Human]] | + | [[Category: Homo sapiens]] |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Jhoti, H]] | + | [[Category: Jhoti H]] |
- | [[Category: Ludlow, R F]] | + | [[Category: Ludlow RF]] |
- | [[Category: Patel, S]] | + | [[Category: Patel S]] |
- | [[Category: Saini, H K]] | + | [[Category: Saini HK]] |
- | [[Category: Tickle, I J]] | + | [[Category: Tickle IJ]] |
- | [[Category: Verdonk, M]] | + | [[Category: Verdonk M]] |
- | [[Category: Alternate binding site]]
| + | |
- | [[Category: At513]]
| + | |
- | [[Category: Chaperone]]
| + | |
- | [[Category: Fragment screening]]
| + | |
- | [[Category: Heat shock]]
| + | |
- | [[Category: Heat shock-related protein]]
| + | |
- | [[Category: Hsp70]]
| + | |
- | [[Category: Hspa2]]
| + | |
- | [[Category: Protein-ligand complex]]
| + | |
| Structural highlights
Function
HSP72_HUMAN In cooperation with other chaperones, Hsp70s stabilize preexistent proteins against aggregation and mediate the folding of newly translated polypeptides in the cytosol as well as within organelles. These chaperones participate in all these processes through their ability to recognize nonnative conformations of other proteins. They bind extended peptide segments with a net hydrophobic character exposed by polypeptides during translation and membrane translocation, or following stress-induced damage.
Publication Abstract from PubMed
Proteins need to be tightly regulated as they control biological processes in most normal cellular functions. The precise mechanisms of regulation are rarely completely understood but can involve binding of endogenous ligands and/or partner proteins at specific locations on a protein that can modulate function. Often, these additional secondary binding sites appear separate to the primary binding site, which, for example for an enzyme, may bind a substrate. In previous work, we have uncovered several examples in which secondary binding sites were discovered on proteins using fragment screening approaches. In each case, we were able to establish that the newly identified secondary binding site was biologically relevant as it was able to modulate function by the binding of a small molecule. In this study, we investigate how often secondary binding sites are located on proteins by analyzing 24 protein targets for which we have performed a fragment screen using X-ray crystallography. Our analysis shows that, surprisingly, the majority of proteins contain secondary binding sites based on their ability to bind fragments. Furthermore, sequence analysis of these previously unknown sites indicate high conservation, which suggests that they may have a biological function, perhaps via an allosteric mechanism. Comparing the physicochemical properties of the secondary sites with known primary ligand binding sites also shows broad similarities indicating that many of the secondary sites may be druggable in nature with small molecules that could provide new opportunities to modulate potential therapeutic targets.
Detection of secondary binding sites in proteins using fragment screening.,Ludlow RF, Verdonk ML, Saini HK, Tickle IJ, Jhoti H Proc Natl Acad Sci U S A. 2015 Dec 11. pii: 201518946. PMID:26655740[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Ludlow RF, Verdonk ML, Saini HK, Tickle IJ, Jhoti H. Detection of secondary binding sites in proteins using fragment screening. Proc Natl Acad Sci U S A. 2015 Dec 11. pii: 201518946. PMID:26655740 doi:http://dx.doi.org/10.1073/pnas.1518946112
|